The necrotising enterocolitis market involves products associated with the treatment and management of necrotising enterocolitis, a disease that affects the intestine of newborn infants. Necrotising enterocolitis is a disease that causes portions of the intestine to die and can be fatal. Some key products in the market include parenteral nutrition solutions and devices for feeding newborns. Parenteral nutrition solutions provide hydration and nutrition to newborns through an intravenous catheter when their digestion cannot support enteral feeding. Additionally, feeding tubes are used to deliver breast milk or formula directly to the stomach or small intestine of infants when oral feeding is not possible.
The Necrotising Enterocolitis Market is estimated to be valued at US$ 7.10 Bn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the necrotising enterocolitis market are AbbVie, AstraZeneca, Baxter International, Bristol-Myers Squibb, Fresenius Kabi.
The key opportunities in the market include increasing research into preventive nutrition strategies and potential drug therapies. There is currently no approved drug for preventing necrotising enterocolitis.
Advancements in parenteral nutrition solutions and feeding devices have improved the ability to provide hydration and nutrients to newborns. Refinements in composition and delivery methods aim to reduce the risk of necrotising enterocolitis.
Market Drivers
A key driver is the rising preterm birth rate globally. Premature infants have an underdeveloped digestive system and are more susceptible to necrotising enterocolitis. As medical technologies improve survival of premature babies, the prevalence of necrotising enterocolitis is also expected to increase. Growing awareness and screening programs in developing regions will also aid in higher detection rates of the disease. This will further fuel the demand for treatment and management products in the necrotising enterocolitis market.
Current Challenges In Necrotising Enterocolitis Market:
Necrotizing enterocolitis continues to be a major challenge for neonatologists and pediatric surgeons. There is no sure way to prevent NEC, and signs and symptoms of this disease are nonspecific. Often it is difficult to diagnose NEC accurately in its early stages. The progression of NEC can be rapid, and appropriate treatment needs to be started promptly to prevent bowel necrosis and perforation which increases mortality and morbidity in babies.
SWOT Analysis
Strength: The growing awareness and diagnostic rate of NEC can help in earlier identification and management. Advancements in neonatal care have improved survival rates of preterm babies who are most prone to NEC.
Weakness: Etiology of NEC is complex with multiple risk factors involved. There is no definite way to prevent its occurrence. Treatment options are also limited once NEC develops severely.
Opportunity: Increased research focus on understanding causes, improved diagnostic methods and novel drug therapies can help reduce mortality and morbidity related to NEC.
Threats: Developing countries still face challenges of lack of optimal neonatal facilities. Social and economic burden of NEC treatment and care is high on families and healthcare systems.
Geographical Regions
North America accounts for the largest share of the necrotizing enterocolitis market in terms of value owing to developed healthcare systems and high treatment costs in the region. Growing prevalence of preterm births along with advanced NICU infrastructure has also boosted the market growth.
Asia Pacific is poised to be the fastest growing region during the forecast period. This can be attributed to improving neonatal care facilities, increasing awareness about NEC, and rising preterm birth rates in developing countries of China and India.
What Are The Key Data Covered In This Necrotising Enterocolitis Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Necrotising Enterocolitis Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Necrotising Enterocolitis Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Necrotising Enterocolitis Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Necrotising Enterocolitis Market vendors
FAQ’s
Q.1 What are the main factors influencing the Necrotising Enterocolitis Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Necrotising Enterocolitis Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Necrotising Enterocolitis Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.